Division of Hematology & Thromboembolism
Clinical Protocols (and Reversals):
Prothrombin Complex Concentrates
Prothrombin Complex Concentrate
Prothrombin Complex Concentrate (PCC) is available through Canadian Blood Services. Two PCCs are currently available, Octaplex and Beriplex; each contains factor II, VII, IX, X, Protein C, Protein S, and small quantities of heparin.
Content |
Octaplex ®from Octapharma |
Beriplex ®from CSL Behring |
| Factor II (IU) | 260-760 |
380-800 |
| Factor VII (IU) | 180-480 |
200-500 |
| Factor IX (IU) | 400-620 |
400-620 |
| Factor X (IU) | 360-600 |
500-1020 |
| Protein C (IU) | 140-620 |
420-820 |
| Protein S (IU) | 140-640 |
240-680 |
| Heparin (IU) | 80-310 |
8-40 |
| Other components | Sodium citrate |
Human antithrombin Human albumin Sodium citrate |
Indications
Treatment of severe or life-threatening acute bleeding in acquired coagulation
defects caused by treatment with vitamin K antagonists (warfarin), or rapid correction (< 6 hours) of the deficiency of vitamin-K dependent
factors required for urgent surgical procedures.
Order must be ap proved by the Thrombosis Service in cases of urgent warfarin
reversal, except in cases of intracranial hemorrhage (to expedite product release).
Dosage
Dosing for target INR ~ 1.5
INR = 2-3: 20 IU/kg
INR = 3-6: 30 IU/kg
INR > 6: 40 IU/kg
* Add 10 IU/kg for target INR < 1.2
* Also give vitamin K 5-10 mg IV over 30 minutes.
* Under normal circumstances the dose should not exceed 3000 IU with a maximum infusion speed of 8mL/min
Supplied
Human product supplied as a lyophilized powder with 20 mL diluent for reconstitution.
Each vial is approximately 500 IU
Each vial contains a range of factor activity eg. Factor IX -400-620 IU
Contraindications
Patients with heparin-induced thrombocytopenia (HIT) or suspected HIT (product contains heparin)
Theodore E. Warkentin MD, BSc (Med), FRCP(C), FACP
Regional Director, Transfusion Medicine
Hamilton Regional Laboratory Medicine Program
Hematologist, Service of Clinical Hematology
Sam Schulman MD
Professor of Medicine
Thrombosis Service, McMaster Clinic & HHS - General Hospital
Mark Crowther MD, MSc, FRCP(C)
Professor and Chair, Division of Hematology & Thromboembolism, McMaster University
Chief, Laboratory Medicine St Joseph's Healthcare and Hamilton Health Sciences, Hamilton


